|
1
|
Vasilets LM, Grigoriadi NE, Karpunina NS,
Tuev AV and Rotanova EA: Immune status of patients with persistent
atrial fibrillation and coronary heart disease. Klin Med (Mosk).
91:32–34. 2013.(In Russian). PubMed/NCBI
|
|
2
|
Zheng H, Tu Y and Teng ZH: Effect of
immune response mediated by antigen-specific T cells on plaque
stability in coronary heart disease. Nan Fang Yi Ke Da Xue Xue Bao.
301610–1611. (1614)2010.(In Chinese). PubMed/NCBI
|
|
3
|
Fu L, Jin L, Yan L, Shi J, Wang H, Zhou B
and Wu X: Comprehensive review of genetic association studies and
meta-analysis on miRNA polymorphisms and rheumatoid arthritis and
systemic lupus erythematosus susceptibility. Hum Immunol. 77:1–6.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mizuguchi Y, Takizawa T, Yoshida H and
Uchida E: Dysregulated miRNA in progression of hepatocellular
carcinoma: A systematic review. Hepatol Res. 46:391–406. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wen MM: Getting miRNA therapeutics into
the target cells for neurodegenerative diseases: A Mini-Review.
Front Mol Neurosci. 9:1292016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yu DD, Lv MM, Chen WX, Zhong SL, Zhang XH,
Chen L, Ma TF, Tang JH and Zhao JH: Role of miR-155 in drug
resistance of breast cancer. Tumour Biol. 36:1395–1401. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lind EF and Ohashi PS: Mir-155, a central
modulator of T-cell responses. Eur J Immunol. 44:11–15. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vigorito E, Kohlhaas S, Lu D and Leyland
R: miR-155: An ancient regulator of the immune system. Immunol Rev.
253:146–157. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu GF, Yang LX, Guo RW, Liu H, Shi YK, Ye
JS and Yang ZH: microRNA-155 is inversely associated with severity
of coronary stenotic lesions calculated by the Gensini score. Coron
Artery Dis. 25:304–310. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fichtlscherer S, De Rosa S, Fox H,
Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Röxe T,
Müller-Ardogan M, et al: Circulating microRNAs in patients with
coronary artery disease. Circ Res. 107:677–684. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang YH, Xia LH, Jin JM, Zong M, Chen M
and Zhang B: Expression level of miR-155 in peripheral blood. Asian
Pac J Trop Med. 8:214–219. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wirtz PH and von Känel R: Psychological
stress, inflammation, and coronary heart disease. Curr Cardiol Rep.
19:1112017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He LY, Zhao JF, Han JL, Shen SS and Chen
XJ: Correlation between serum free fatty acids levels and Gensini
score in elderly patients with coronary heart disease. J Geriatr
Cardiol. 11:57–62. 2014.PubMed/NCBI
|
|
15
|
Che J, Li G, Wang W, Li Q, Liu H, Chen K
and Liu T: Serum autoantibodies against human oxidized low-density
lipoproteins are inversely associated with severity of coronary
stenotic lesions calculated by Gensini score. Cardiol J.
18:364–370. 2011.PubMed/NCBI
|
|
16
|
Jia QW, Chen ZH, Ding XQ, Liu JY, Ge PC,
An FH, Li LH, Wang LS, Ma WZ, Yang ZJ, et al: Predictive effects of
circulating miR-221, miR-130a and miR-155 for coronary heart
disease: A multi-ethnic study in China. Cell Physiol Biochem.
42:808–823. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu J, Chen T, Yang L, Li Z, Wong MM,
Zheng X, Pan X, Zhang L and Yan H: Regulation of microRNA-155 in
atherosclerotic inflammatory responses by targeting MAP3K10. PLoS
One. 7:e465512012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tian FJ, An LN, Wang GK, Zhu JQ, Li Q,
Zhang YY, Zeng A, Zou J, Zhu RF, Han XS, et al: Elevated
microRNA-155 promotes foam cell formation by targeting HBP1 in
atherogenesis. Cardiovasc Res. 103:100–110. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pan RY, Liu P, Zhou HT, Sun WX, Song J,
Shu J, Cui GJ, Yang ZJ and Jia EZ: Circular RNAs promote TRPM3
expression by inhibiting hsa-miR-130a-3p in coronary artery disease
patients. Oncotarget. 8:60280–60290. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Farrokhian A, Raygan F, Soltani A,
Tajabadi-Ebrahimi M, Esfahani Sharifi M, Karami AA and Asemi Z: The
effects of synbiotic supplementation on carotid intima-media
thickness, biomarkers of inflammation, and oxidative stress in
people with overweight, diabetes, and coronary heart disease: A
randomized, double-blind, placebo-controlled trial. Probiotics
Antimicrob Proteins. Oct 27–2017.(Epub ahead of print). doi:
10.1007/s12602-017-9343-1. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Louafi F, Martinez-Nunez RT and
Sanchez-Elsner T: MicroRNA-155 targets SMAD2 and modulates the
response of macrophages to transforming growth factor-{beta}. J
Biol Chem. 285:41328–41336. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jiang S, Zhang HW, Lu MH, He XH, Li Y, Gu
H, Liu MF and Wang ED: MicroRNA-155 functions as an OncomiR in
breast cancer by targeting the suppressor of cytokine signaling 1
gene. Cancer Res. 70:3119–3127. 2010. View Article : Google Scholar : PubMed/NCBI
|
